2022 | 11 C-Acetate PET/CT Detects Reactive Astrogliosis Helping Glioma Classification | CLINICAL NUCLEAR MEDICINE |
2024 | 11C-Acetate PET/CT for Reactive Astrogliosis Outperforms 11C-Methionine PET/CT in Glioma Classification and Survival Prediction | CLINICAL NUCLEAR MEDICINE |
2021 | A diagnostic tree for differentiation of adult pilocytic astrocytomas from high-grade gliomas | EUROPEAN JOURNAL OF RADIOLOGY |
2022 | A fully automatic multiparametric radiomics model for differentiation of adult pilocytic astrocytomas from high-grade gliomas | EUROPEAN RADIOLOGY |
2020 | A National Consensus Survey for Current Practice in Brain Tumor Management I: Antiepileptic Drug and Steroid Usage
| Brain Tumor Research and Treatment |
2020 | A National Consensus Survey for Current Practice in Brain Tumor Management II: Diffuse Midline Glioma and Meningioma
| Brain Tumor Research and Treatment |
2020 | A National Consensus Survey for Current Practice in Brain Tumor Management III: Brain Metastasis and Primary Central Nervous System Lymphoma
| Brain Tumor Research and Treatment |
2022 | A novel biguanide (IM1761065) inhibits bioenergetics of glioblastoma tumorspheres | JOURNAL OF NEURO-ONCOLOGY |
2019 | A PHLDB1 variant associated with the nonfunctional pituitary adenoma | JOURNAL OF NEURO-ONCOLOGY |
2020 | A rare case of oligodendroglioma with gangliocytic differentiation in a 31-year-old male: importance of genetic testing for IDH1/2 | BRAIN TUMOR PATHOLOGY |
2022 | Adding radiomics to the 2021 WHO updates may improve prognostic prediction for current IDH-wildtype histological lower-grade gliomas with known EGFR amplification and TERT promoter mutation status | EUROPEAN RADIOLOGY |
2020 | Ambient carbon monoxide exposure and elevated risk of mortality in the glioblastoma patients: A double-cohort retrospective observational study
| CANCER MEDICINE |
2018 | Amide proton transfer imaging for differentiation of benign and atypical meningiomas | EUROPEAN RADIOLOGY |
2019 | Amide proton transfer imaging might predict survival and IDH mutation status in high-grade glioma | EUROPEAN RADIOLOGY |
2017 | Amide proton transfer imaging to discriminate between low- and high-grade gliomas: added value to apparent diffusion coefficient and relative cerebral blood volume | EUROPEAN RADIOLOGY |
2022 | An interpretable radiomics model to select patients for radiotherapy after surgery for WHO grade 2 meningiomas
| RADIATION ONCOLOGY |
2019 | Analysis of patterns of failure and appraisal of postoperative radiation field for grade II-III meningioma | Journal of Neuro-Oncology |
2019 | Angioleiomyoma in the Orbital Apex: A Case Report
| Brain Tumor Research and Treatment |
2022 | Asian-specific 3'UTR variant in CDKN2B associated with risk of pituitary adenoma | MOLECULAR BIOLOGY REPORTS |
2018 | Association analysis of RTEL1 variants with risk of adult gliomas in a Korean population
| PLOS ONE |
2020 | Association between survival and levetiracetam use in glioblastoma patients treated with temozolomide chemoradiotherapy
| SCIENTIFIC REPORTS |
2022 | Association of MGMT Gene Promoter Methylation With Clinicopathological Parameters in Patients With Wild-type IDH Glioblastoma | ANTICANCER RESEARCH |
2023 | Astrocytic scar restricting glioblastoma via glutamate-MAO-B activity in glioblastoma-microglia assembloid
| Biomaterials Research |
2020 | ATM mutations improve radio-sensitivity in wild-type isocitrate dehydrogenase-associated high-grade glioma: retrospective analysis using next-generation sequencing data
| RADIATION ONCOLOGY |
2013 | Changes in the biological characteristics of glioma cancer stem cells after serial in vivo subtransplantation. | CHILDS NERVOUS SYSTEM |
2002 | Chronic epidural hematoma with rapid ossification | CHILDS NERVOUS SYSTEM |
2022 | Clinical and diffusion parameters may noninvasively predict TERT promoter mutation status in grade II meningiomas | JOURNAL OF NEURORADIOLOGY |
2022 | Clinical factors and conventional MRI may independently predict progression-free survival and overall survival in adult pilocytic astrocytomas | NEURORADIOLOGY |
2019 | Clinical predictors of radiation-induced lymphopenia in patients receiving chemoradiation for glioblastoma: clinical usefulness of intensity-modulated radiotherapy in the immuno-oncology era
| RADIATION ONCOLOGY |
2022 | Clinicopathological differences in radiation-induced organizing hematomas of the brain based on type of radiation treatment and primary lesions
| JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE |
2020 | Co-expression ofcancer driver genes: IDH-wildtype glioblastoma-derived tumorspheres
| JOURNAL OF TRANSLATIONAL MEDICINE |
2020 | Comparison of Diagnostic Performance of Two-Dimensional and Three-Dimensional Fractal Dimension and Lacunarity Analyses for Predicting the Meningioma Grade
| Brain Tumor Research and Treatment |
2017 | Concurrent Chemoradiotherapy with Temozolomide Followed by Adjuvant Temozolomide for Newly Diagnosed Glioblastoma Patients: A Retrospective Multicenter Observation Study in Korea
| CANCER RESEARCH AND TREATMENT |
2020 | Crosstalk between GBM cells and mesenchymal stemlike cells promotes the invasiveness of GBM through the C5a/p38/ZEB1 axis | NEURO-ONCOLOGY |
2004 | Cysticercosis of cerebellopontine cistern: differential diagnosis using MRI | ACTA NEUROCHIRURGICA |
2021 | Differentiation of recurrent diffuse glioma from treatment-induced change using amide proton transfer imaging: incremental value to diffusion and perfusion parameters | NEURORADIOLOGY |
2021 | Differentiation of recurrent glioblastoma from radiation necrosis using diffusion radiomics with machine learning model development and external validation
| SCIENTIFIC REPORTS |
2020 | Diffusion and perfusion MRI may predict EGFR amplification and the TERT promoter mutation status of IDH-wildtype lower-grade gliomas | EUROPEAN RADIOLOGY |
2021 | Diffusion tensor and postcontrast T1-weighted imaging radiomics to differentiate the epidermal growth factor receptor mutation status of brain metastases from non-small cell lung cancer | NEURORADIOLOGY |
2020 | Diffusion tensor imaging radiomics in lower-grade glioma: improving subtyping of isocitrate dehydrogenase mutation status | NEURORADIOLOGY |
2016 | Down-regulation of MicroRNA-126 in Glioblastoma and its Correlation with Patient Prognosis: A Pilot Study | ANTICANCER RESEARCH |
2021 | Dynamic contrast-enhanced MRI may be helpful to predict response and prognosis after bevacizumab treatment in patients with recurrent high-grade glioma: comparison with diffusion tensor and dynamic susceptibility contrast imaging | NEURORADIOLOGY |
2023 | Dynamic contrast-enhanced MRI radiomics model predicts epidermal growth factor receptor amplification in glioblastoma, IDH-wildtype | JOURNAL OF NEURO-ONCOLOGY |
2014 | Early response to high-dose methotrexate, vincristine, and procarbazine chemotherapy-adapted strategy for primary CNS lymphoma: no consolidation therapy for patients achieving early complete response. | ANNALS OF HEMATOLOGY |
2023 | Efficacy and safety of metformin plus low-dose temozolomide in patients with recurrent or refractory glioblastoma: a randomized, prospective, multicenter, double-blind, controlled, phase 2 trial (KNOG-1501 study)
| DISCOVER ONCOLOGY |
2017 | Elderly patients with newly diagnosed glioblastoma: can preoperative imaging descriptors improve the predictive power of a survival model? | JOURNAL OF NEURO-ONCOLOGY |
2013 | Existence of glioma stroma mesenchymal stemlike cells in Korean glioma specimens | CHILDS NERVOUS SYSTEM |
2020 | Extent of resection and molecular pathologic subtype are potent prognostic factors of adult WHO grade II glioma
| SCIENTIFIC REPORTS |
2016 | Failure of a patient-derived xenograft for brain tumor model prepared by implantation of tissue fragments.
| CANCER CELL INTERNATIONAL |
2014 | Feasibility and Outcomes of Hypofractionated Simultaneous Integrated Boost-Intensity Modulated Radiotherapy for Malignant Gliomas: A Preliminary Report
| YONSEI MEDICAL JOURNAL |
2021 | Fully automated hybrid approach to predict the IDH mutation status of gliomas via deep learning and radiomics
| NEURO-ONCOLOGY |
2020 | Glioblastomas harboring gene fusions detected by next-generation sequencing | BRAIN TUMOR PATHOLOGY |
2016 | Histopathological implications of ventricle wall 5-aminolevulinic acid-induced fluorescence in the absence of tumor involvement on magnetic resonance images. | ONCOLOGY REPORTS |
2018 | Human glioblastoma arises from subventricular zone cells with low-level driver mutations. | NATURE |
2021 | Identification of magnetic resonance imaging features for the prediction of molecular profiles of newly diagnosed glioblastoma | JOURNAL OF NEURO-ONCOLOGY |
2011 | Immunoglobulin G4-related hypertrophic pachymeningitis involving cerebral parenchyma. | JOURNAL OF NEUROSURGERY |
2019 | Impact of H3.3 K27M Mutation on Prognosis and Survival of Grade IV Spinal Cord Glioma on the Basis of New 2016 World Health Organization Classification of the Central Nervous System | NEUROSURGERY |
2017 | Impact of Including Peritumoral Edema in Radiotherapy Target Volume on Patterns of Failure in Glioblastoma following Temozolomide-based Chemoradiotherapy
| SCIENTIFIC REPORTS |
2013 | Increased in vivo angiogenic effect of glioma stromal mesenchymal stem-like cells on glioma cancer stem cells from patients with glioblastoma | INTERNATIONAL JOURNAL OF ONCOLOGY |
2016 | Incremental Prognostic Value of ADC Histogram Analysis over MGMT Promoter Methylation Status in Patients with Glioblastoma | RADIOLOGY |